FDA tentatively approves Lupin’s generic Locoid lotion

Press enter to search
Close search
Open Menu

FDA tentatively approves Lupin’s generic Locoid lotion

By David Salazar - 02/13/2018
The Food and Drug Administration has granted tentative approval to Lupin’s generic Locoid Lotion (hydrocortisone butyrate, 0.1%).

Lupin’s generic Locoid Lotion is indicated for the topical treatment of mild to moderate atopic dermatitis. The product had U.S. sales of roughly $16.1 million for the 12 months ended October 2017, according to IQVIA data.

 

Related Topics